I'm LongbridgeAI, I can summarize articles.Oracle (ORCL) fell 7.12% this week to close at $137.10, while the S&P 500 rose 1.21%, leaving the stock about 8.33 percentage points behind the benchmark. The week followed a rise-then-fade pattern: Monday held near $148.56, Tuesday touched a weekly high of $153.60, and Wednesday slipped below $145. The heaviest damage came on Thursday, when the stock dropped to a weekly low of $133.48, before settling near $137 on Friday. Weekly amplitude was 13.
The Week
Oracle (ORCL) fell 7.12% this week to close at $137.10, while the S&P 500 rose 1.21%, leaving the stock about 8.33 percentage points behind the benchmark. The week followed a rise-then-fade pattern: Monday held near $148.56, Tuesday touched a weekly high of $153.60, and Wednesday slipped below $145. The heaviest damage came on Thursday, when the stock dropped to a weekly low of $133.48, before settling near $137 on Friday. Weekly amplitude was 13.51%, with average daily volume of about 31.3m shares, roughly 4% above the 60-day median.
Key Events
The main story this week was data-centre delivery risk. Bloomberg News reported on 24 September that Oracle had cited ‘force majeure’ to shield itself on a controversial data-centre project. Investor concern over a potential setback grew from there, and the shares sold off hard on Thursday. The news rippled through AI infrastructure names: Bloom Energy and other partners moved sharply, and the market framed the delay warning as a sign of broader problems in the AI build-out, including power and permitting delays.
Funding pressure accompanied the project risk. Analysts noted that the Oracle and Blue Owl project delay sent ripples through AI financing, with related bonds tumbling to a record low and discussion of Oracle paying a premium on AI debt. Oracle also disclosed that Executive Chairman and CTO Lawrence J. Ellison received total compensation of $131 million for 2026, and Google said the ShinyHunters group had expanded attacks on Oracle’s PeopleSoft.
Analyst Ratings
Among 45 institutions covering Oracle, 27 rate it buy, 8 rate it overweight, 7 rate it hold, 1 rates it sell, and 2 have no opinion. The consensus recommendation is buy, with a consensus target of $237.97, implying about 73.58% upside from the current price. The target range is wide, from $110 to $400, pointing to meaningful dispersion. Oracle ranks 6th out of 46 stocks in the systems software industry.
The Week Ahead
On the macro side, next week opens with the Dallas Fed manufacturing business activity index, followed by FHFA house prices and Case Shiller home price data, then JOLTS job openings and consumer confidence midweek. For Oracle itself, the data-centre force majeure announcement will remain in focus, with investors watching for any update on project timelines and the knock-on effects across AI financing.
In Short
The week’s decline ran alongside data-centre uncertainty, while the analyst picture stayed broadly constructive: most brokers rate Oracle buy or overweight, and the consensus target sits well above spot, though the range is extremely wide. On the latest trading day, small-lot money was a net buyer while large-lot money was a net seller. Valuation sits near 22x earnings. What matters next is how the market prices the delay risk, and whether AI infrastructure funding conditions tighten further.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.